JP2009544314A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009544314A5 JP2009544314A5 JP2009521815A JP2009521815A JP2009544314A5 JP 2009544314 A5 JP2009544314 A5 JP 2009544314A5 JP 2009521815 A JP2009521815 A JP 2009521815A JP 2009521815 A JP2009521815 A JP 2009521815A JP 2009544314 A5 JP2009544314 A5 JP 2009544314A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nucleotide position
- nucleotide
- change
- deletion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002773 nucleotide Substances 0.000 claims 116
- 125000003729 nucleotide group Chemical group 0.000 claims 116
- 238000012217 deletion Methods 0.000 claims 23
- 230000037430 deletion Effects 0.000 claims 23
- 238000003780 insertion Methods 0.000 claims 18
- 230000037431 insertion Effects 0.000 claims 18
- 238000000034 method Methods 0.000 claims 15
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 14
- 208000010061 Autosomal Dominant Polycystic Kidney Diseases 0.000 claims 13
- 208000022185 autosomal dominant polycystic kidney disease Diseases 0.000 claims 13
- 230000004075 alteration Effects 0.000 claims 11
- 238000012986 modification Methods 0.000 claims 10
- 230000004048 modification Effects 0.000 claims 10
- 150000007523 nucleic acids Chemical class 0.000 claims 6
- 238000003752 polymerase chain reaction Methods 0.000 claims 6
- 101100029888 Homo sapiens PKD1 gene Proteins 0.000 claims 4
- 101150056230 PKD1 gene Proteins 0.000 claims 4
- 101150112863 pkd2 gene Proteins 0.000 claims 4
- 238000001514 detection method Methods 0.000 claims 3
- 238000004128 high performance liquid chromatography Methods 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 238000012163 sequencing technique Methods 0.000 claims 3
- 102100037310 Serine/threonine-protein kinase D1 Human genes 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 101001074444 Homo sapiens Polycystin-1 Proteins 0.000 claims 1
- 101001074439 Homo sapiens Polycystin-2 Proteins 0.000 claims 1
- 101001026882 Homo sapiens Serine/threonine-protein kinase D2 Proteins 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83278006P | 2006-07-24 | 2006-07-24 | |
| PCT/US2007/016705 WO2008094194A2 (en) | 2006-07-24 | 2007-07-24 | Pkd mutations and evaluation of same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009544314A JP2009544314A (ja) | 2009-12-17 |
| JP2009544314A5 true JP2009544314A5 (enExample) | 2010-10-07 |
Family
ID=39674638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009521815A Pending JP2009544314A (ja) | 2006-07-24 | 2007-07-24 | Ｐｋｄの変異およびその評価 |
Country Status (4)
| Country | Link |
|---|---|
| US (4) | US8771946B2 (enExample) |
| JP (1) | JP2009544314A (enExample) |
| CA (3) | CA3081362C (enExample) |
| WO (1) | WO2008094194A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008094194A2 (en) | 2006-07-24 | 2008-08-07 | Athena Diagnostics, Inc. | Pkd mutations and evaluation of same |
| GB201410693D0 (en) | 2014-06-16 | 2014-07-30 | Univ Southampton | Splicing modulation |
| EP3201339A4 (en) | 2014-10-03 | 2018-09-19 | Cold Spring Harbor Laboratory | Targeted augmentation of nuclear gene output |
| US10538812B2 (en) | 2014-11-19 | 2020-01-21 | Otsuka Pharmaceutical Co., Ltd. | Primer set and method for amplifying exons of PKD1 gene and PKD2 gene |
| EP3359685A1 (en) | 2015-10-09 | 2018-08-15 | University Of Southampton | Modulation of gene expression and screening for deregulated protein expression |
| WO2017106211A1 (en) * | 2015-12-14 | 2017-06-22 | Cold Spring Harbor Laboratory | Antisense oligomers for treatment of polycystic kidney disease |
| US11096956B2 (en) | 2015-12-14 | 2021-08-24 | Stoke Therapeutics, Inc. | Antisense oligomers and uses thereof |
| KR102604132B1 (ko) | 2015-12-14 | 2023-11-17 | 콜드스프링하버러보러토리 | 상염색체 우성 정신 지체 5 및 드라베 증후군의 치료를 위한 안티센스 올리고머 |
| SI3673080T1 (sl) | 2017-08-25 | 2024-03-29 | Stoke Therapeutics, Inc. | Protismiselni oligomeri za zdravljenje bolezenskih stanj in bolezni |
| BR112020022512A2 (pt) | 2018-05-04 | 2021-05-04 | Stoke Therapeutics, Inc. | métodos e composições para tratamento de doença de armazenamento de éster de colesteril |
| AU2021270720A1 (en) | 2020-05-11 | 2022-12-08 | Stoke Therapeutics, Inc. | OPA1 antisense oligomers for treatment of conditions and diseases |
| CN115725716B (zh) * | 2022-09-20 | 2024-04-30 | 湖南家辉生物技术有限公司 | Pkd1致病突变基因及在制备多囊肾病诊断试剂盒中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0733110A1 (en) * | 1993-12-24 | 1996-09-25 | University of Wales College of Medicine | Tuberous sclerosis 2 gene and uses thereof |
| US6867288B1 (en) | 1994-10-12 | 2005-03-15 | Genzyme Corporation | Polycystic kidney disease gene |
| US6031088A (en) * | 1996-05-23 | 2000-02-29 | Albert Einstein College Of Medicine Of Yeshiva University | Polycystic kidney disease PKD2 gene and uses thereof |
| US6100386A (en) * | 1996-11-01 | 2000-08-08 | Cold Spring Harbor Laboratory | Human gene/protein involved in chronic myelogenous leukemia |
| WO2002006529A2 (en) | 2000-07-13 | 2002-01-24 | The Johns Hopkins University School Of Medicine | Detection and treatment of polycystic kidney disease |
| US6916619B2 (en) * | 2001-10-12 | 2005-07-12 | Athena Diagnostics, Inc. | Compositions and methods for genetic analysis of polycystic kidney disease |
| US7273701B2 (en) * | 2001-10-12 | 2007-09-25 | Athena Diagnostics, Inc. | Compositions and methods for genetic analysis of polycystic kidney disease |
| CA2872385C (en) * | 2003-04-11 | 2019-01-15 | Athena Diagnostics, Inc. | Compositions and methods for genetic analysis of polycystic kidney disease |
| WO2008094194A2 (en) | 2006-07-24 | 2008-08-07 | Athena Diagnostics, Inc. | Pkd mutations and evaluation of same |
-
2007
- 2007-07-24 WO PCT/US2007/016705 patent/WO2008094194A2/en not_active Ceased
- 2007-07-24 JP JP2009521815A patent/JP2009544314A/ja active Pending
- 2007-07-24 US US12/309,337 patent/US8771946B2/en active Active
- 2007-07-24 CA CA3081362A patent/CA3081362C/en active Active
- 2007-07-24 CA CA2658421A patent/CA2658421C/en active Active
- 2007-07-24 CA CA2993381A patent/CA2993381C/en active Active
-
2014
- 2014-05-28 US US14/289,160 patent/US10760128B2/en active Active
-
2020
- 2020-08-31 US US17/008,385 patent/US11655508B2/en active Active
-
2023
- 2023-04-05 US US18/131,204 patent/US20230374593A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009544314A5 (enExample) | ||
| Ehrenkaufer et al. | Identification of developmentally regulated genes in Entamoeba histolytica: insights into mechanisms of stage conversion in a protozoan parasite | |
| JP2020505920A5 (enExample) | ||
| Nikaido et al. | Discovery of imprinted transcripts in the mouse transcriptome using large-scale expression profiling | |
| US20120220478A1 (en) | Methods for assessing disease risk | |
| JP2008526249A5 (enExample) | ||
| JP2010075182A5 (enExample) | ||
| JP2010508042A5 (enExample) | ||
| JP2014533949A5 (enExample) | ||
| JP2014509189A5 (enExample) | ||
| JP2011519275A5 (enExample) | ||
| JP2011528903A5 (enExample) | ||
| JP2011530312A5 (enExample) | ||
| CN107858423B (zh) | 用于预测心源性猝死易感性的试剂盒 | |
| WO2008016615A3 (en) | Methods for high sensitivity detection of genetic polymorphisms | |
| KR20090078341A (ko) | Ｄｎａｊ 유전자를 사용한 박테리아의 검출, 및 그의 용도 | |
| JP2013544536A5 (enExample) | ||
| KR101546058B1 (ko) | 대사증후군 예측용 ｓｎｐ 마커 및 이의 용도 | |
| Chen et al. | Transcriptomes of six mutants in the Sen1 pathway reveal combinatorial control of transcription termination across the Saccharomyces cerevisiae genome | |
| EP2195453A2 (en) | Method of amplifying nucleic acid | |
| EP2689034B1 (en) | Role of ifng methylation in inflammatory bowel disease | |
| CA2608161A1 (en) | Methods for the assesssment of risk of developing lung cancer using analysis of genetic polymorphisms | |
| JP5427352B2 (ja) | ヒト体脂肪量と関連する遺伝子多型に基づく肥満発症リスクの判定方法 | |
| JP4491276B2 (ja) | 標的ｄｎａ配列において一塩基変異多型の存在を検出する方法及びキット | |
| CN102827834A (zh) | 甲亢疾病的易感基因及其应用 |